Author:
Bawolak Marie-Thérèse,Lodge Robert,Morissette Guillaume,Marceau François
Funder
Canadian Institutes of Health Research
Fonds de Recherche du Québec - Santé
Reference19 articles.
1. Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies;Abd Alla;J. Biol. Chem.,1996
2. Bradykinin B2 receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates;Bachvarov;J. Pharmacol. Exp. Ther.,2001
3. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) Is an Inactivation-Resistant Agonist of the Bradykinin B2Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): Pharmacologic Profile and Effective Induction of Receptor Degradation
4. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging;Bawolak;Peptides,2008
5. Effects of inactivation-resistant agonists on the signalling, desensitization and down-regulation of bradykinin B2 receptors;Bawolak;Br. J. Pharmacol.,2009
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献